Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank86
3Y CAGR+13.2%
5Y CAGR+19.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+13.2%/yr
vs +10.3%/yr prior
5Y CAGR
+19.9%/yr
Recent deceleration
Acceleration
+2.9pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$114.88M-1.6%
2024$116.73M-21.0%
2023$147.74M+86.4%
2022$79.27M+10.6%
2021$71.65M+54.7%
2020$46.33M-17.7%
2019$56.31M+5.2%
2018$53.53M-9.0%
2017$58.81M+26.3%
2016$46.55M-